Tate & Lyle plc (LON:TATE)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 2.49B +49.1% |
| Revenue (ttm) | 2.01B +15.6% |
| Net Income | 97.00M -32.2% |
| EPS | 0.22 -37.1% |
| Shares Out | 442.56M |
| PE Ratio | 25.88 |
| Forward PE | 15.15 |
| Dividend | 0.20 (3.52%) |
| Ex-Dividend Date | Jun 18, 2026 |
| Volume | 13,328 |
| Open | 562.50 |
| Previous Close | 561.50 |
| Day's Range | 561.50 - 562.50 |
| 52-Week Range | 319.40 - 580.00 |
| Beta | 0.34 |
| Analysts | Hold |
| Price Target | 554.44 (-1.35%) |
| Earnings Date | Nov 5, 2026 |
About Tate & Lyle
Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours. The company’s products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal... [Read more]
Financial Performance
In fiscal year 2026, Tate & Lyle's revenue was 2.01 billion, an increase of 15.55% compared to the previous year's 1.74 billion. Earnings were 97.00 million, a decrease of -32.17%.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for TATE stock is "Hold." The 12-month stock price target is 554p, which is a decrease of -1.35% from the latest price.
News
Tate & Lyle downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Damian McNeela downgraded Tate & Lyle to Hold from Buy with an unchanged price target of 595 GBp. The firm cites Ingredion’s firm offer for Tate for…
Tate & Lyle downgraded to Neutral from Outperform at BNP Paribas
BNP Paribas downgraded Tate & Lyle to Neutral from Outperform with a 595 GBp price target
Tate & Lyle: From sugar barons in London's East End to US takeover
Tate & Lyle on Monday agreed to a £2.7 billion ($3.6 billion) takeover in cash from U.S.-based Ingredion , marking a new chapter for one of Britain's oldest industrial names and creating a global food...
Ingredion to Take Over Tate & Lyle in $3.6 Billion Deal
Ingredion offered the equivalent of $7.94 for each Tate & Lyle share, a 59% premium to the last closing price before takeover talks were disclosed last month.
Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle
Creates a scaled global provider of specialty ingredient solutions for a healthier, tastier and more sustainable future of food Broadens Ingredion's specialty ingredients platform across texturants, ...
UK's Tate & Lyle agrees $3.6 billion Ingredion takeover
Britain's Tate & Lyle has agreed to a £2.7 billion ($3.60 billion) offer from U.S. rival Ingredion , the companies said on Monday, creating a food and beverage ingredients major.
Tate & Lyle Earnings Call Transcript: H2 2026
Integration of CP Kelco is complete, supporting a broader solutions offering and early signs of top-line momentum. FY results met revised guidance, with revenue and EBITDA down 3% like-for-like, and a GBP 20 million bio-gums headwind expected in FY 2027.
Tate & Lyle Annual report: H2 2026
Tate & Lyle has published its H2 2026 annual report on May 21, 2026.
Tate & Lyle Slides: H2 2026
Tate & Lyle has posted slides in relation to its H2 2026 quarterly earnings report, which was published on May 21, 2026.
Tate & Lyle Annual report: H2 2026
Tate & Lyle has published its H2 2026 annual report on May 21, 2026.
Ingredion Takeover Target Tate & Lyle Posts Fall in Profit
The British ingredients company reported lower profit for what it called a disappointing fiscal year.
Tate & Lyle downgraded to Hold from Buy at Kepler Cheuvreux
Kepler Cheuvreux downgraded Tate & Lyle to Hold from Buy with a 547 GBp price target
Ingredion confirms non-binding all-cash offer of 595p/share for Tate & Lyle
In a regulatory filing, Ingredion (INGR) issued a statement regarding a non-binding all-cash offer by the company for Tate & Lyle PLC (TATYY). “Ingredion confirms it has made a non-binding…
Tate & Lyle In Talks With Ingredion Over $3.7 billion Takeover Offer
The proposed offer value is a 64% premium to the London-listed food-and-beverage ingredient company's closing share price Wednesday.
Britain's Tate & Lyle in discussions with US rival Ingredion for $3.7 billion takeover bid
Britain's Tate & Lyle on Thursday said it was in discussions with U.S. rival Ingredion over a possible takeover of the food ingredients maker, valuing it at 2.74 billion pounds ($3.70 billion), ...
Tate & Lyle price target lowered to 375 GBp from 390 GBp at UBS
UBS analyst Priyanka Patel lowered the firm’s price target on Tate & Lyle to 375 GBp from 390 GBp and keeps a Neutral rating on the shares. Published first on…
Tate & Lyle price target lowered to 375 GBp from 399 GBp at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Tate & Lyle to 375 GBp from 399 GBp and keeps an Underweight rating on the shares.
Tate & Lyle price target lowered to 500 GBp from 540 GBp at Citi
Citi lowered the firm’s price target on Tate & Lyle to 500 GBp from 540 GBp and keeps a Buy rating on the shares.
Tate & Lyle Earnings Call Transcript: Q3 2026
Q3 results were in line with expectations, with muted demand leading to a 2% pro forma revenue decline, but reported revenue rose 15% due to the CP Kelco acquisition. Strategic investments and strong customer engagement in innovation and fiber fortification support future growth.
Tate & Lyle Earnings release: Q3 2026
Tate & Lyle released its Q3 2026 earnings on February 26, 2026, summarizing the period's financial results.
Tate & Lyle initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Sam Darbyshire initiated coverage of Tate & Lyle with a Neutral rating and 410 GBp price target The firm say says the company has limited visibility into…
Tate & Lyle Earnings Call Transcript: H1 2026
Integration of CP Kelco is driving strong customer engagement and a robust new business pipeline, but near-term performance is impacted by weak market demand, especially in North America. Revenue and EBITDA are expected to decline slightly for the year, with cost and revenue synergies from the acquisition tracking ahead of plan.
Tate & Lyle Quarterly report: H1 2026
Tate & Lyle has published its H1 2026 quarterly earnings report on November 6, 2025.
Tate & Lyle Slides: H1 2026
Tate & Lyle has posted slides in relation to its H1 2026 quarterly earnings report, which was published on November 6, 2025.
Tate & Lyle price target lowered to 450 GBp from 620 GBp at Berenberg
Berenberg lowered the firm’s price target on Tate & Lyle to 450 GBp from 620 GBp and keeps a Hold rating on the shares.